Lisa Scherer

Title: The Innovative Contributions of Lisa Scherer

Introduction

Lisa Scherer is a prominent inventor based in Monrovia, California, known for her significant contributions to the field of biotechnology. With a total of eight patents to her name, she has made remarkable advancements in therapeutic technologies, particularly in the treatment of cardiac conditions.

Latest Patents

Among her latest patents is the invention titled "Conditional-siRNAS and uses thereof in treating cardiac hypertrophy." This patent discloses conditional siRNAs that are activatable by pro-hypertrophic RNA sequences, aimed at treating conditions such as cardiac hypertrophy. The conditional siRNAs specifically target calcineurin or HDAC2, showcasing her innovative approach to addressing serious health issues. Another notable patent is "Meta-stable oligonucleotides junctions for delivery of therapeutics." This invention describes multi-way oligonucleotide junctions designed for delivering one or more cargo molecules to a biological target. The junctions are stable outside the cell and easily dissociate inside the cell, allowing for targeted delivery of therapeutic agents.

Career Highlights

Lisa has worked with esteemed institutions such as the California Institute of Technology and City of Hope. Her work in these organizations has allowed her to push the boundaries of research and development in her field.

Collaborations

Throughout her career, Lisa has collaborated with notable professionals, including William A. Goddard III and John J. Rossi. These collaborations have further enriched her research and contributed to her innovative projects.

Conclusion

Lisa Scherer exemplifies the spirit of innovation in biotechnology through her groundbreaking patents and collaborations. Her work continues to pave the way for advancements in medical treatments, particularly in cardiac health.